For example, GLP-1 RA administration downregulates the conversion of astrocytes, inhibits neurodegeneration, and prevents cognitive impairments in animal models of Alzheimer’s disease [44]. Here, GCG is linked to early-onset autosomal dominant Alzheimer disease.